632624-40-9

Basic information

• Product Name: Benzoic acid, 3-(acetylamino)-5-[2-[5-chloro-2-[(2,3-difluorophenyl)methoxy]phenyl]-5- methyl-1H-pyrrol-1-yl]-
• CAS NO: 632624-40-9
• Molecular Formula: C27H21ClF2N2O4
• Molecular Weight: 510.925
• Mol File: 632624-40-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-(acetylamino)-5-[2-[5-chloro-2-[(2,3-difluorophenyl)methoxy]phenyl]-5- methyl-1H-pyrrol-1-yl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-(acetylamino)-5-[2-[5-chloro-2-[(2,3-difluorophenyl)methoxy]phenyl]-5- methyl-1H-pyrrol-1-yl]-(632624-40-9)
• EPA Substance Registry System: Benzoic acid, 3-(acetylamino)-5-[2-[5-chloro-2-[(2,3-difluorophenyl)methoxy]phenyl]-5- methyl-1H-pyrrol-1-yl]-(632624-40-9)

Safety Data

• Hazardous Substances Data: 632624-40-9(Hazardous Substances Data)

Upstream product

• 113211-94-2 2,3-difluorobenzyl bromide 
• 635-93-8 5-chlorosalicyclaldehyde 
• 632627-62-4 1-[5-chloro-2-(2,3-difluorobenzyloxy)phenyl]-pentane-1,4-dione 
• 15089-84-6 3-acetylamino-5-aminobenzoic acid 

Relevant articles and documents

PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES

Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine, in particular their use in the treatment of prostaglandin mediated diseases such as pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.